AVTRMed Selected as Member of NVIDIA Inception Program, Advancing its Enterprise AI Platform for Healthcare Delivery

Carbonatix Pre-Player Loader

Audio By Carbonatix

Selection validates AVTRMed's technical architecture and accelerates its go-to-market strategy for scaling its intelligent automation platform

DAKOTA DUNES, SOUTH DAKOTA / ACCESS Newswire / February 9, 2026 / AVTRMed, Inc., a healthcare AI company building autonomous clinical workflow solutions, today announced its acceptance into the NVIDIA Inception program, a global initiative supporting startups developing transformative technologies in artificial intelligence and accelerated computing.

The NVIDIA Inception program provides AVTRMed with access to NVIDIA's advanced AI frameworks, infrastructure, technical expertise and capabilities to scale its eye care platform and later expand to additional healthcare verticals. Selection into the program validates AVTRMed's technical architecture and solidifies its position in the rapidly growing AI-enabled healthcare sector.

"Joining NVIDIA Inception is a strategic milestone that validates our mission and strengthens our foundation for sustained growth," says Dr. Steven Ferguson, CEO of AVTRMed. "This collaboration empowers AVTRMed to deliver high-impact clinical and operational AI solutions at scale, alongside leading innovators in healthcare AI."

AVTRMed is developing a next-generation platform designed to address structural inefficiencies in healthcare delivery through intelligent, autonomous digital workflows. The company's AI Clinic Assistant is currently deployed in live clinical eye care environments, demonstrating meaningful reductions in administrative workload and improvements in patient appointment adherence. As healthcare organizations increasingly seek AI solutions that deliver immediate ROI and integrate seamlessly with existing infrastructure, AVTRMed's focus on performance and enterprise deployment positions the company to capture value in a market undergoing fundamental transformation.

NVIDIA Inception fuels AVTRMed's ability to scale and future-proof its platform without compromising the rigorous security and compliance that healthcare demands.

For more information about AVTRMed and its AI platform, visit AVTRMed.com or connect with the company on LinkedIn.

About AVTRMed, Inc.

AVTRMed is a healthcare AI company building scalable platforms that augment clinical and operational workflows through advanced artificial intelligence. The company's mission is to enable more efficient, accessible and human-centered healthcare delivery. AVTRMed's AI Clinic Assistant platform serves eye care practices with autonomous solutions for patient engagement and administrative automation. Learn more at www.avtrmed.com.

About NVIDIA Inception

NVIDIA Inception is designed to nurture startups revolutionizing industries with technological advancements. The program provides critical go-to-market support, expertise, and technology to members across the globe, spanning diverse industries from healthcare and finance to automotive and manufacturing. For more information, visit nvidia.com/en-us/startups.

END

Media Contact:

Brian Regan, COO

Phone: (919) 229-9594

Email: [email protected]

SOURCE: AVTRMed

View the original press release on ACCESS Newswire
 

Trending Videos

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • Bloomberg Businessweek
    8:00AM - 10:00AM
     
    Get the latest news from the world of business and finance and the interesting   >>
     
  • Money Pulse
    10:00AM - 10:30AM
     
    Host Dynasti Young and Craig Roberts talk to innovative startups and enduring businesses here in the Bay Area.
     
  • Business By The Bay
    10:30AM - 11:00AM
     
    San Francisco Bay Area has given the world some of the greatest business   >>
     
  • InvestTalk with Justin Klein and Luke Guerrero
     
    InvestTalk™ serves as your go-to educational platform to delve into the   >>
     
  • Best Stocks Now
    12:00PM - 1:00PM
     
    Bill Gunderson provides listeners with financial guidance that is both   >>
     

See the Full Program Guide